Epidemiology of gastrooesophageal reflux disease: A systematic review

被引:1312
作者
Dent, J
El-Serag, HB
Wallander, MA
Johansson, S
机构
[1] Royal Adelaide Hosp, Dept Gastroenterol Hepatol & Gen Med, Adelaide, SA 5000, Australia
[2] Houston Vet Affairs Med Ctr 152, Gastroenterol Sect, Houston, TX USA
[3] AstraZeneca R&D, SE-43183 Molndal, Sweden
关键词
D O I
10.1136/gut.2004.051821
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A systematic review of the epidemiology of gastro-oesophageal reflux disease (GORD) has been performed, applying strict criteria for quality of studies and the disease definition used. The prevalence and incidence of GORD was estimated from 15 studies which defined GORD as at least weekly heartburn and/or acid regurgitation and met criteria concerning sample size, response rate, and recall period. Data on factors associated with GORD were also evaluated. An approximate prevalence of 10-20% was identified for GORD, defined by at least weekly heartburn and/or acid regurgitation in the Western world while in Asia this was lower, at less than 5%. The incidence in the Western world was approximately 5 per 1000 person years. A number of potential risk factors (for example, an immediate family history and obesity) and comorbidities (for example, respiratory diseases and chest pain) associated with GORD were identified. Data reported in this systematic review can be interpreted with confidence as reflecting the epidemiology of "true'' GORD. The disease is more common in the Western world than in Asia, and the low rate of incidence relative to prevalence reflects its chronicity. The small number of studies eligible for inclusion in this review highlights the need for global consensus on a symptom based definition of GORD.
引用
收藏
页码:710 / 717
页数:8
相关论文
共 55 条
[1]  
Agréus L, 2001, AM J GASTROENTEROL, V96, P2905
[2]  
[Anonymous], 2004, ALIMENT PHARM THER, DOI DOI 10.1111/j.1365-2036.2004.01897.x
[3]   Reflux symptoms are associated with psychiatric disease [J].
Avidan, B ;
Sonnenberg, A ;
Giblovich, H ;
Sontag, SJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) :1907-1912
[4]   Gastroesophageal reflux disease in monozygotic and dizygotic twins [J].
Cameron, AJ ;
Lagergren, J ;
Henriksson, C ;
Nyren, O ;
Locke, GR ;
Pedersen, NL .
GASTROENTEROLOGY, 2002, 122 (01) :55-59
[5]   Risk factors for Barrett's esophagus: A case-control study [J].
Conio, M ;
Filiberti, R ;
Blanchi, S ;
Ferraris, R ;
Marchi, S ;
Ravelli, P ;
Lapertosa, G ;
Iaquinto, G ;
Sablich, R ;
Gusmaroli, R ;
Aste, H ;
Giacosa, A .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (02) :225-229
[6]  
Corder AP, 1996, BRIT J CLIN PRACT, V50, P245
[7]   An evidence-based appraisal of reflux disease management - the Genval workshop report [J].
Dent, J ;
Brun, J ;
Fendrick, AM ;
Fennerty, MB ;
Janssens, J ;
Kahrilas, PJ ;
Lauritsen, K ;
Reynolds, JC ;
Shaw, M ;
Talley, NJ .
GUT, 1999, 44 :S1-S16
[8]   Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population [J].
Diaz-Rubio, M ;
Moreno-Elola-Olaso, C ;
Rey, E ;
Locke, GR ;
Rodriguez-Artalejo, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (01) :95-105
[9]   Gastroesophageal reflux among different racial groups in the United States [J].
El-Serag, HB ;
Petersen, NJ ;
Carter, J ;
Graham, DY ;
Richardson, P ;
Genta, RM ;
Rabeneck, L .
GASTROENTEROLOGY, 2004, 126 (07) :1692-1699
[10]   Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease [J].
El-Serag, HB ;
Johanson, JF .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (08) :899-904